Invested $39,544 this round & $1,116,170 previously
Syndicate Lead
Invested $1,155,714
Invested $39,544 this round & $1,116,170 previously
“The Tempo SPE Group manages Angel investment into 10 startups, 4 of which are in health care. Gryt provides significant assistance for patients to find solutions to their cancer diagnosis. One of our startups is using Gryt to assist in a clinical trial. I am on the Board of that startup and I recommended Gryt.
It is important for investors to complete their diligence before they invest in startups. Tempo has done so and continues to invest for Gryt provides an excellent service to patient...”
2x Testicular Cancer Survivor, Patient Experience Researcher and Pharma Executive
Shelley NoldenBoard Chair & Angel Investor
Leukemia Survivor, Founding Member of a Wall Street Firm
Brad LoveBoard Member & Chief Culture Officer
Associate Director, Center for Health Communication, University of Texas
Bill WalshChief Financial Officer
Cancer Survivor, Former General Motors Financial Analyst
Uma RanaChief of Strategic Partnerships
Pharma Executive in Digital Health, Transformation & Strategy
David AleksandrowiczChief Information Officer
Cancer Caregiver, Entrepreneur and Software Developer
Sheila ThorneBoard Member
Expertise in designing and implementing multicultural marketing campaigns for the pharmaceutical, biotech and medical device industry
Guy Boike, MDBoard Member
Dr. Boike has over 40 years of experience in gynecological cancer treatment and has been published in many peer-reviewed publications and research studies.
Gryt Health (‘grit’) amplifies voices to improve health outcomes. Gryt is a healthtech company owned by survivors and caregivers. By always putting the patient experience first, we work to improve medicine development, access to equitable care and outcomes for all. Visit grythealth.com to learn more.
Through our innovative, patient engagement platform, Gryt provides clinical trial patient activation, patient experience research, and patient engagement services to the majority of the Top 10 global pharmaceutical companies. Additionally, we work with clinical research organizations, life sciences and biotech companies who are leading cutting edge new treatment development.
![[object Object] profile photo](https://wefunder.com/rails/active_storage/blobs/redirect/eyJfcmFpbHMiOnsiZGF0YSI6MTg2MjM0LCJwdXIiOiJibG9iX2lkIn19--f74e4f72938671332126de05cc3f597d1f814ec9/excellpartners.webp)
![[object Object] profile photo](https://wefunder.com/rails/active_storage/blobs/redirect/eyJfcmFpbHMiOnsiZGF0YSI6MTk0MDgwLCJwdXIiOiJibG9iX2lkIn19--4328741e7acdae6151740358a0772da468083270/dteziyooxhn78ndxfxbq.webp)
![[object Object] profile photo](https://wefunder.com/rails/active_storage/blobs/redirect/eyJfcmFpbHMiOnsiZGF0YSI6MTk0MTA1LCJwdXIiOiJibG9iX2lkIn19--c0622fdcd33f5f205349688c9c6cb5194e659a94/xcrqzhzhnfw0st8kdqvp.webp)
![[object Object] profile photo](https://wefunder.com/rails/active_storage/blobs/redirect/eyJfcmFpbHMiOnsiZGF0YSI6MTk0MTA3LCJwdXIiOiJibG9iX2lkIn19--ba7b200bf2c74f7b9802d78fe783f15100428925/ftfhkx1wrpimffslvnwc.webp)
